Your Health Magazine Contributor
4201 Northview Drive
Suite 102
Bowie, MD 20716
More Kratom Education Articles
New in Botanical Products: Two Recent Launches From Kats Botanicals and Real Botanicals
The botanical products market continues to introduce new formulations, with manufacturers exploring everything from flavoured plant extracts to multi-ingredient tablets.
Two recent developments illustrate the different directions companies are taking. Kats Botanicals has expanded its kava gummy selection with two new tropical flavours, while Real Botanicals has introduced Mit-OH, a concentrated formulation combining kratom-derived mitragynine with other ingredients.
Although the products differ considerably in their composition and intended audience, both launches highlight the growing variety of formats within the botanical products category.
Here’s a closer look at what’s new from each company.
Kats Botanicals Introduces Two New Kava Gummy Flavours
Kats Botanicals has expanded its kava product lineup with the introduction of Dragonfruit and Pineapple Upside Down Cake gummies.
Announced in the company’s November 2026 newsletter, the additions build on its existing selection of kava products, which includes powders, extracts, tinctures, and gummies.
Kava comes from the root of Piper methysticum, a plant traditionally prepared as a beverage in parts of the South Pacific. Its naturally occurring compounds, known as kavalactones, are central to the ingredient’s effects.
Rather than requiring consumers to prepare a traditional kava drink, Kats Botanicals has incorporated kava extract into flavoured gummies.
The two new varieties offer distinct flavour profiles. Dragonfruit has a lighter tropical taste, while Pineapple Upside Down Cake takes inspiration from the familiar dessert, combining pineapple notes with a richer flavour profile.
According to the company, each gummy contains 50 mg of noble kava extract standardized to 90% kavalactones.
The new flavours join its existing Berry gummies, expanding the selection without changing the underlying kava formulation.
Kats Botanicals also states that its products undergo third-party laboratory testing to evaluate potency and potential contaminants. The company makes Certificates of Analysis available for consumers to review.
For a manufacturer already offering several forms of kava, the introduction of additional flavours represents a relatively straightforward approach to product development: expanding variety within an established product category.
More information about the formulations is available through the Kats Botanicals kava gummy collection.
Real Botanicals Launches Mit-OH Tablets
Real Botanicals has also introduced a new product, although its approach differs significantly from Kats Botanicals’ latest release.
The company’s Mit-OH tablets combine purified mitragynine, a naturally occurring alkaloid found in the kratom plant, with Corydalis yanhusuo root extract and paraxanthine, a compound produced when the body metabolizes caffeine.
According to Real Botanicals, the product is available in formulations labeled 150 mg and 300 mg. These concentrations warrant particular attention because concentrated kratom alkaloids can carry risks that differ from those associated with traditional botanical preparations.
Unlike traditional kratom powders, which contain a broader mixture of plant compounds, Mit-OH uses a concentrated extract formulation.
Real Botanicals says its ChromaPure purification process is intended to create a more clearly defined alkaloid profile. The company also provides laboratory documentation for its Mit-OH products.
The tablets have a scored design, which the manufacturer identifies as a product feature. However, this should not be interpreted as guidance on safe consumption, and no clinically established safe dosage has been determined for this formulation.
An important distinction is that Mit-OH is not the same substance as 7-hydroxymitragynine, commonly called 7-OH. Real Botanicals states that 7-OH is not an ingredient in the Mit-OH formulation.
That distinction is particularly relevant as federal and state authorities continue to scrutinize concentrated kratom-related substances and their regulatory status.
However, the absence of added 7-OH should not be interpreted as evidence that a concentrated mitragynine product is safe or clinically effective.
The manufacturer’s Real Botanicals Mit-OH product information provides its stated ingredient specifications and laboratory documentation. These materials describe the product’s composition but do not establish FDA approval, clinical safety, or effectiveness.
Different Products, Different Approaches to Development
While both launches fall within the broader botanical products market, they demonstrate two distinct approaches to formulation.
Kats Botanicals is building on an existing kava gummy product by introducing new flavours. Its latest development focuses on the presentation of a familiar formulation.
Real Botanicals, meanwhile, has introduced a multi-ingredient tablet involving a concentrated kratom-derived alkaloid, with a more complex formulation and different considerations around potency and regulation.
The distinction matters because botanical products are not interchangeable simply because their ingredients originate from plants.
Extraction methods, concentrations, additional ingredients, and the amount of each active compound can vary substantially from one product to another.
For consumers evaluating these products, ingredient disclosure and independent testing can provide useful information about composition and manufacturing consistency. However, laboratory testing alone does not establish that a product is safe or effective.
There are also important health considerations. Kava products have been associated with rare but sometimes serious liver injury, while kratom and concentrated mitragynine products carry risks that include dependence, adverse reactions, and potential interactions with medications. The U.S. Food and Drug Administration has not approved kratom for any medical use.
These considerations make accurate labeling, responsible marketing, and compliance with applicable regulations particularly important.
What’s Next for Botanical Product Innovation?
The recent announcements from Kats Botanicals and Real Botanicals show how varied product development can be within the botanical market.
One company is expanding an established kava line through new flavours, while the other is introducing a different formulation built around purified botanical compounds.
For manufacturers, new releases create opportunities to respond to consumer preferences and explore different product formats. For consumers, they also make it increasingly important to understand exactly what a product contains and how it differs from other offerings.
As more botanical products enter the market, transparent ingredient information, verifiable testing, and responsible communication will remain essential considerations alongside innovation.
Other Articles You May Find of Interest...
- New in Botanical Products: Two Recent Launches From Kats Botanicals and Real Botanicals
- Is Kratom Safe? What Doctors Want Patients to Know
- How HPLC Testing Verifies Botanical Potency—and Why Lab Results Can Differ
- Red Bali Kratom: What It Is, How It Differs, and What the Research Says
- Kratom Legality in 2026: Why the Rules Vary by Location
- 7 Things to Know About Split Kilo Kratom Before a Bulk Order
- Red Thai Kratom: The Strain With a Complicated History and a Loyal Following











